Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001346824-25-000019·Jade Biosciences, Inc.
Schedule 13G ownership disclosure
Jade Biosciences Inc
Common Stock, $0.0001 par value per share · CUSIP: 008064206
Event date: 2025-10-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 3,214,969.00 · Class: 7.0%
- Peter Kolchinsky
Shares: 3,214,969.00 · Class: 7.0%
- Rajeev Shah
Shares: 3,214,969.00 · Class: 7.0%
- RA Capital Healthcare Fund, L.P.
Shares: 3,214,969.00 · Class: 7.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001346824-25-000019
- Form type
- SCHEDULE 13G
- Filer
- Jade Biosciences, Inc.
- CIK
- CIK 1798749
- Filed
- Oct 16, 2025
- Reporting period
- Oct 08, 2025
- Description
- Schedule 13G beneficial ownership